lilly tirzepatide self pay releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Lilly lowers the price of

Results Ongoing clinical oversight is provided throughout the program to reinforce healthy lifestyle behaviors, monitor metabolic response, and maintain accountability

December 3, 2025- Many states have decided to refuse coverage for the GLP-1 weight-loss drugs for obese patients who dont have type 2 diabetes, evading a likelihood to lower cancer rates, diabetes and heart disease

Storage & Handling Recommendations Store unopened vials in a cool, dry environment away from direct sunlight and excessive heat

As a result of the findings, the product information of all GLP-1 and dual GIP/GLP-1 RAs has been updated to include the potential risk of pulmonary aspiration under general anaesthesia or deep sedation, the MHRA said